Wang et al. found that the expression of APOF at both the mRNA and protein levels in hepatocellular carcinoma was significantly downregulated, and low APOF expression was associated with poor RFS in hepatocellular carcinoma patients [38]. The gene discussed is APOF; the disease is hepatocellular carcinoma.